What does Tenax Therapeutics, Inc. do?
Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing products for critical care, particularly acutely decompensated heart failure. It has a market cap of $23.56 million and reported a net profit loss of $10 million as of March 2025.
Overview:Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the critical care market, specifically targeting conditions such as acutely decompensated heart failure. The company operates within the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap entity.Financial Snapshot:
Most recent Net Profit: -10 Million (Quarterly Results - Mar 2025)
Market cap: USD 23.56 Million (Micro Cap)
Key Metrics:
P/E: NA (Loss Making)
Dividend Yield: 0.00%
Debt Equity: -1.02
Return on Equity: -22.15%
Price to Book: 0.22
Contact Details:
Address: One Copley Parkway, Suite 490, MORRISVILLE NC: 27560
Tel: ['1 919 8064414', '1 919 8552112']
Fax: 1 302 6745266
Website: http://www.tenaxthera.com/
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
